Compare Albemarle Corp. (ALB) vs Cytokinetics Inc (CYTK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Albemarle Corp. vs Cytokinetics Inc — how do they compare? Albemarle Corp. trades at $131.2 (market cap $15.27B), while Cytokinetics Inc trades at $76.67 (market cap $10.63B). The key difference: Albemarle Corp. is the larger of the two by market cap, and Albemarle Corp. pays a 1.27% dividend while Cytokinetics Inc pays none. Which is the better fit depends on your goals.
| ALB | CYTK | |
|---|---|---|
Market Cap | $15.27B | $10.63B |
Sector | Basic Materials | Technology |
52-Week High | $215.62 | $87.26 |
52-Week Low | $72.58 | $34.31 |
Enterprise Value | $17.75B | $10.74B |
Dividend Yield | 1.27% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Albemarle Corp.
Albemarle is the world's largest lithium producer. Our outlook for robust lithium demand is predicated upon increased demand for electric vehicle batteries. Albemarle produces lithium from its salt brine deposits in Chile and the U.S. and its hard rock joint venture mines in Australia. Albemarle is also a global leader in the production of bromine, used in flame retardants. The company is also a major producer of oil refining catalysts.
Read more on ALB →About Cytokinetics Inc
Cytokinetics is a biopharmaceutical company focused on muscle biology. It develops muscle activators and inhibitors as potential treatments for debilitating diseases where muscle performance is compromised or declining.
Read more on CYTK →
